[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-IPSC":3,"homepage-market-summary":31,"stock-news-IPSC":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"IPSC","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Century Therapeutics, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.","78","Philadelphia, PA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},1.48,1.58,1.59,1.4545,1.53,-0.05,-3.27,771333.718326,3491,1.4855,3.04,0.435,1269174.995712498,40.1,1330,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":39,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":40,"sparkline":75,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":14,"sparkline":90,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.56,200.93,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.73,53.88,{"name":110,"etf":111,"change":112,"price":113,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.99,63.44,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",1.31,49.5,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":145,"etf":146,"change":117,"price":147,"is_up":40},"Utilities","XLU",39.97,{"name":149,"etf":150,"change":151,"price":152,"is_up":40},"Comm Services","XLC",1.17,111.61,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":160,"name":161,"price":162,"change":163,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":165,"name":166,"price":167,"change":168,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":170,"name":171,"price":172,"change":39,"is_up":40},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":174,"articles":175},9,[176,182,188,194,200,206,212,217,222],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Diabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxPVU54ellWM2t0em1fV3F6QUN5a0NwYThfb1h4dzZZZVlSSWliYmV5QkVrd2FBYllQTm0tbl9qY053LUoxNTh2RXdsdHZzaldNY2JRRzFfY3VkZWVEcFpxOFVGbHRuVWF3Tzc4anY5V0o5bzZxdnVaLU1jMHFpQl9mcGRRRy1YZTg3Sm0wWUYwaWlKMDVFX1R5UFZRZC00dGFRYzdpY1lGNGt5YzN5bEp4M2hkaFBfQ0dKRi1R?oc=5","Fri, 02 Oct 2026 12:05:00 GMT","Diabetic mice kept normal blood sugar until the transplant was removed. The study lasted over 11 months. Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxOcE1yczlOcU0yVU0wVUpiSXpJVFBsREhFNUN1YVVscnJGR0VXOEtTWnlFS2ROa21aVmtaZWNfcHlnaVpXUW9QQmZ2MlVjQ3JUN2JTZXdTSjdjZFVCUWZObnlvQ0R5OVkzTk5BMThPcjlpbjNjdC1maGUzc0dvaFBXY2M0R1NYX3RvdVBIOUJFNEgyU0dtSzliVi01UUpweEZwV19feUVfMnFCLThxYXhmaHo4elVLZw?oc=5","Wed, 30 Sep 2026 08:27:06 GMT","Century Therapeutics: Competitors May Be Quietly De-Risking Its Biggest Bet (NASDAQ:IPSC) Seeking Alpha","Seeking Alpha",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxOb3lIWnhJVnd3TkhUWUVZeG0zdTVmRXZkemhsLVNYYXlXNTJUSnNRYlVsZGRJV2pWcHFMam9OSUp2R0xNTE96bDdYS0tHSXhsZ296VGlTd2pvLWxTN0MwWE52UXJvZXlaZWxreHpmOEstN0FSd1ZEcnJQcXc0Q29raDRyRS1CNkFWNXN3OGV5YzdHbTJqaWFoWWJjcnhua3JUZmFoc3kxdm1ZMGZaNDhvODRweEZRVDFxR3lxUHZZZnBOamdyOTFOVkxydndwNFh3am5MdQ?oc=5","Mon, 28 Sep 2026 03:37:10 GMT","Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch Stocktwits","Stocktwits",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Century Therapeutics presents preclinical data for T1D therapy By Investing.com - Investing.com South Africa","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxOdFppYU9fakxzYlVtV2pwYjN1aXBDOUhXMmpuWDZnaUtscEtCR2cwWURMTEF1RmJ1OFBrWnM4bkNhdDZTVl9wSTdjSWlZeWYwX2ljalJYVHBVNU5mY3FlaFYzb081Q2JaUFBiYVlpRnZfNnZTcGstRmh3VGxsYkxlUks3QmNCQTU1dTlIbnNldnlPMkVlaXNxWjdjMW1NZFVybVUwWUd5QmpkWnFzR19vS1hmTjBpU3Z5aVg4QmFMb2Y?oc=5","Fri, 02 Oct 2026 13:23:26 GMT","Century Therapeutics presents preclinical data for T1D therapy By Investing.com Investing.com South Africa","Investing.com South Africa",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Century Therapeutics appoints Truitt. Century Therapeutics stock has USD 309.6 million value. - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiygFBVV95cUxNX0x2cm56QU5PcHlyV2Q1TTdyYzFsc1pLV0ZNaFpvVW55WEtISlVqOFNrVFNPMzF4NDBOZ2QtXzRsODhKR3oySzdYcnptLWpYdmJFc2dLY3lGVmlpUWpMZC1DSWZNU1UtSGdVTVBaZEk5ZUhqVGRBbmRFTnBvdUtORjNrS0lJQUZyVW5EbjRMRTg0M0RvaUlmUkNRRXhDVDl0S1F2VUhGWThROUVaQnFlb3RLNHBNU3VQWTV1dENhbjFxN0VsZ1RsdmFB?oc=5","Thu, 01 Oct 2026 09:15:45 GMT","Century Therapeutics appoints Truitt. Century Therapeutics stock has USD 309.6 million value. AD HOC NEWS","AD HOC NEWS",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi9gFBVV95cUxPcFZySUo0Y2xnM0pfc3FLQlN4RnZtRjNtaTVrQ1pFdkhRN1BzWnRKem9uZVpkSmh6d0FmQ3BPMXJaQkZCYzNxQmZLWVhXd3BJRHpONVYwNUlnUXFiUzAyUklEbzNqNTQwRnVTeHRZOXVaalNINm9SbllHTWNUcUtxaTNGZ1JCSktSOGs1ZG0xbjN2dnItRE1iRW4tLXBtMk9ueXNFcGZuSmpESWxLWmR3SVBhVjM4Z1ZyYVAyaGhjXzdxVEYzUkh3dld3TEVCNG96b2hENUVSVkloSkJ2dFZQNlZvbkZBbm11ZWJVS08yUHE2ZTRBSEHSAfsBQVVfeXFMTnBzWnFPdGItSmdRRXJ4WkNoU0llWW8yUWhMNjllLUR4Um85dVpnMmJjdEJ3TDhxLWpYd0t6ZWVkLTBodkNFcklDNERQMEsyQ3Bmd3h0Mng4MS12aUxEdHlJZllxU3lCQ3lON0ZjdXFmdE1nWTRiNE9vUmhBS3VkZDl3MkZjNXpSdmVTX1NjSkJHS3hYanJ4enh3dkM4VHk5dm5vMGw0TklKc0ZNaEdma1JSbGxRR2JOOGsyeUJxald2TDJlenR5dXdHa0l6dVNiR0tYb2ZHQWNaVjNTaWM0eTVrWUJCQUk0M29oTDNhSG1DclpNaG1DQUNLSTQ?oc=5","Fri, 02 Oct 2026 11:03:56 GMT","Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) The Manila Times","The Manila Times",{"title":213,"link":214,"pubDate":215,"description":216,"source":181},"Two new hires at Fate Therapeutics get stock awards that vest over four years if they stay - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxOU2Y3Qll6UVNOeVVsTkJqekRoc3FBN1g4RHZCVTdYaWxHRUVPN0l2NmFpQ1dNWVFVVDVLYk5FclJqcF9zcUZlTk05WUp6ejMzak56Y1NLc3otaFhVVkQ4eEFDRl9odFdLekdTUzAtRWRCb1VFd3c4SGtTNl9uUGhiZUZxOGJsUlQzakVtaUU4bUl2US13TzlQcGJNZ2k1NnBhM0hJYUo1NGhpSHZXX1NMbGJZa3JoUkxi?oc=5","Fri, 02 Oct 2026 11:00:00 GMT","Two new hires at Fate Therapeutics get stock awards that vest over four years if they stay Stock Titan",{"title":218,"link":219,"pubDate":220,"description":221,"source":205},"Evotec stock after-hours at EUR 2.92: minus 4.26 percent - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxNVHB5OEFfbkR6Q1c3c3BNZ2pGNzYxdExJSWJfemZyRkFvZmpETC1hMnF3cU5ZNEZIWEJ4NVFXd1RiZU9sTktieDhLd2hzY3BWeEF2VU1WdUg1SlhFeVVyRm5JbnFTdkp5U0NoMWlkMWxGWHFlMjlDbGlNdkMyTGdTMlowZ0I0LUVQd0plNHI3cGFGQWh5SU1ORVRabHRDd2RZQ0RHSUZ5VmtwRTF0Rk53MHJ4UVI?oc=5","Fri, 02 Oct 2026 16:49:51 GMT","Evotec stock after-hours at EUR 2.92: minus 4.26 percent AD HOC NEWS",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"Century Therapeutics advances CNTY-813 islet therapy program - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxPeDBoanRodWJ2YWlpUzJYUEVRRzJPczVFVWtXR2FBQ3ZoZ1JKN0lVWTlCRkRIeDY5QkVYU1h4enBIY3BmeVR0X1NOZHFHcGpCa3BxZURSMDc4a1dpZXVHbVBobEdIYnVjcTM1ZXF5WkFJZWVLT19PR1hjRUdrYUdvZkFBVG8xcUNPTUgxdkdCUkxCVmVsbVlWdzNDU3lkcFpTTURETHVfQUdnSUtiUU5YbWhR?oc=5","Fri, 02 Oct 2026 13:01:11 GMT","Century Therapeutics advances CNTY-813 islet therapy program TipRanks","TipRanks"]